Pharma partnerships
Pharma
partnerships
From Molecular Biology to personalized Medicine
“The right drug, for the right patient, at the right time”: this summarizes Diatech Pharmacogenetics mission; to always create innovative diagnostic solutions and advance the world of pharmacogenetics and precision medicine for better patient outcome.
Diatech Pharmacogenetics
Milestones
+500
active sites
in 40+ countries. A decentralized testing approach to improve patients access to personalised medicine.
+500K
test
worldwide with Diatech molecular testing solutions.
25
years
experience in molecular biology with a specific focus on IVD development, production and commercialization.
+50
CE-IVD products
One of the largest IVD portfolio with a main focus on precision medicine.
Research Keywords:
– Precision Medicine
– Precision Diagnostics
– Companion Diagnostics
– Pharmacogenetics
– In Vitro Diagnostics IVD
– Personalized Medicine
– Pharma – Partners
EasyPGX
the first
RT-NGS System –
Democratize molecular oncology
One established, robust and standardized platform to be used either for RT-PCR and library prep with the largest oncology applications portfolio in the market.
Personalized
medicine portfolio
ALK | ERBB2 | KRAS | PML-RARA |
BCR-ABL | ESR1 | MET | PPARG |
BCR-ABL P190 | FGFR2 | MSI | RET |
BCR-ABL P210 | FGFR3 | NRAS | ROS1 |
BRAF | HRAS | NTRK1 | UGT1A1 |
BRCA1 | HRD | NTRK2 | WT1 |
BRCA2 | IDH1 | NTRK3 | |
DPYD | IDH2 | PDGFRA | |
EGFR | KIT | PIK3CA |
ALK | ERBB2 | KRAS | PML-RARA |
BCR-ABL | ESR1 | MET | PPARG |
BCR-ABL P190 | FGFR2 | MSI | RET |
BCR-ABL P210 | FGFR3 | NRAS | ROS1 |
BRAF | HRAS | NTRK1 | UGT1A1 |
BRCA1 | HRD | NTRK2 | WT1 |
BRCA2 | IDH1 | NTRK3 | |
DPYD | IDH2 | PDGFRA | |
EGFR | KIT | PIK3CA |
Future development pipeline
Future
development
pipeline